Indivior Pharmaceuticals Inc
USD40.45
+1.33 (+3.40%)
CEO
Joseph J. Ciaffoni
IPO Date
2014-12-29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$38.96
Prev. Close
$39.12
Day Low
$38.76
Day High
$40.52
52W Low
$15.91
52W High
$42.81
Market Cap
$5.05B
Volume
1.23M
| 1,266,903 |
| $0.00 |
| 23 Jun 2026 | Ciaffoni Joseph | director, officer: Chief Executive Officer | F-InKind | Disposed | 612,549 | $38.32 |
| 23 Jun 2026 | Ciaffoni Joseph | director, officer: Chief Executive Officer | M-Exempt | Disposed | 1,266,903 | $0.00 |
| 12 Jun 2026 | Heidbreder Christian | Chief Scientific Officer | S-Sale | Disposed | 18,586 | $38.06 |
| 10 Jun 2026 | Preblick Ryan | Chief Financial Officer | S-Sale | Disposed | 36,000 | $37.70 |
| 14 May 2026 | Thompson Juliet | director | F-InKind | Disposed | 1,117 | $38.28 |
| 14 May 2026 | Thompson Juliet | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Humphreys Keith | director | A-Award | Acquired | 6,518 | $0.00 |
| 14 May 2026 | Kingsley Stuart A | director | A-Award | Acquired | 6,518 | $0.00 |